)
)
Phathom Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Phathom Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Phathom Pharmaceuticals Inc
Access all reports
Phathom Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. The company’s research is centered around novel therapies that address acid-related disorders, such as gastroesophageal reflux disease (GERD) and related conditions. Phathom aims to provide new treatment options that improve the management of these chronic conditions, particularly in areas where current therapies may be inadequate. The company is headquartered in Florham Park, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PHAT
Country
🇺🇸 United States